This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Establishing Centers of Excellence and leveraging artificial intelligence for pharma research can advance India’s capabilities in NCEs, biologics, and biosimilars, placing it at the forefront of global pharma innovation. Enable global competitiveness The MedTech sector aspires to reduce import dependence and become globally competitive.
News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)
Related Videos Related Content Advertisement June 11th 2025 Perioperative Nivolumab Shows Long-Term EFS, Favorable OS in Resectable NSCLC Luke Halpern, Assistant Editor June 3rd 2025 S2.
Ximluci is expected to be available in the UK in 2023 The approval for Ximluci was granted through the EC decision reliance procedure, whereby the MHRA’s decision was based on the EC Ximluci was approved in the UK for wet AMD, DME, diabetic retinopathy, RVO, and visual impairment due to choroidal neovascularization in adults.
The medical team, in collaboration with pharmacists, opted to use rilonacept and worked to expedite its delivery to the patient upon hospital discharge. What we did was we admitted him to the hospital. " But that's not such a wise thing, and I believe he was 85 years old, so we decided to admit him.
Fresenius has invested nearly $1bn for the manufacture as well as distribution of Vasopressin to serve hospitals and health systems in the US. Patients may also suffer from reversible diabetes insipidus after stopping treatment with vasopressin.
Fresenius has invested nearly $1bn for the manufacture as well as distribution of Vasopressin to serve hospitals and health systems in the US. Patients may also suffer from reversible diabetes insipidus after stopping treatment with vasopressin.
News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)
News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)
His wife Neeta along with friends, rush him to Asclepius Hospital. It was a diabetic coma caused by a traditional medicine which inadvertently led to hypoglycemia. Even today, the first line treatment for diabetes is diet and exercise. Suddenly he collapses. This is the fact. It is for you to get it enforced”. “Done Dr. Reddy.”
Addepalli Veeranjaneyulu and Shubhadeep Debabrata Sinha introduced the session by describing the function of PV in the safety profiles of biosimilars. To provide the audience with an Indian viewpoint, the presenters pointed out the country's requirements for biosimilar PV. Dr. Mangesh.
One study from the American Society of Health-System Pharmacists found that GLP-1 treatments were a main driver of the increase in overall drug spending by health entities such as pharmacies and hospitals last year. billion, making the drug the top-selling medicine in 2023. Continue to STAT+ to read the full story…
The NHC recognizes that Medicare already covers AOMs for patients who are overweight and have comorbid conditions such as diabetes or cardiovascular disease. To further strengthen these efforts, the NHC recommends that CMS adopt additional measures to ensure broad access to generics, biosimilars, and other cost-effective treatments.
Shots: With an incurable nature and hefty medication costs, diabetes mellitus remains a global health concern and the seventh leading cause of death across the world. Diabetes, aka diabetes mellitus is a condition that arises when the pancreas fails to produce enough insulin or the cells of the body do not respond to the insulin produced.
Secondary outcomes included rates of specialist referrals and asthma-related emergency department (ED) visits or hospitalizations. Asthma exacerbations requiring acute care were rare but notable: 1 patient visited the ED, and 3 were hospitalized, all of whom were in the track 2 group.
For example, CPAs are especially impactful in managing chronic conditions such as diabetes, heart failure, and rheumatoid arthritis, where pharmacist intervention has been shown to improve outcomes and reduce hospitalizations. Creating disease-specific competency assessments also ensures alignment with evolving standards of care.
The convenience of once-daily dosing and a rapid IV bolus administration may offer workflow efficiencies in hospital or surgical settings, where minimizing polypharmacy and streamlining medication administration are important goals. December 21, 2004. Subscribe Now!
1 Image credit: Talia Mdlungu/peopleimages.com | stock.adobe.com Baptist Health South Florida is a nonprofit health system comprising 12 hospitals, 4500 physicians, and 200 outpatient facilities. Within this expansive network, the neurology clinical pharmacy specialist serves a vital dual role.
News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)
Some will assume roles in hospitals and health systems, long-term care, telehealth models, and other roles. MacKinnon III, PhD, DMSc (Hon), MS, RPh, FASHP, FNAP We should begin to refer to these pharmacists in direct-to-career paths accordingly as “primary care pharmacists.”
News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)
News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)
1,2 MASH, formerly known as nonalcoholic steatohepatitis, is a severe form of metabolic dysfunction-associated steatotic liver disease (MASLD) that often accompanies various metabolic diseases (eg, obesity and diabetes). Major risk factors of HCC are metabolic dysfunction-associated steatohepatitis (MASH) and viral hepatitis.
At Children’s Hospital of Philadelphia (CHOP), eligible patients can access 12 advanced therapeutics and 8 more in the pipeline. These treatments are already in widespread use across health systems, from Mayo Clinic’s 9 active and 5 pending to University of California (UC) San Diego Health’s 12 active and 5 under review.
The initial therapeutic focus is diabetes, with three insulin-based products in development. The Group’s third insulin product is a stable co-formulation of pramlintide and insulin, which has the potential to be a next generation treatment for both type 1 and type 2 diabetes.
Abbott spun off its hospital product business into an independent company called Hospira on the other hand its breakthrough drug Humira achieved a global sale of more than $0.8B The company faced a tough time in 2019 as the first biosimilars for its best-selling drugs (Rituxan, Avastin, and Herceptin) emerged.
Conducted across 15 hospitals, 774 patients aged 18 years or older with untreated, stage II to III, invasive HER2+ breast cancer were enrolled between April 30, 2021, and August 27, 2024. If caught early, the cancer can often be treated and cured, according to Cleveland Clinic. Of note, the adjuvant phase of the trial is currently ongoing.
News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)
About the Author Brianne Perry, PharmD, is an acute care PGY-1 resident at LDS Hospital with Intermountain Health. I took her advice and celebrated by starting a new book and going to a nice dinner with my husband, which was much needed. She aims to pursue her pharmacist career after completing residency in 2025.
News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)
News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)
The prospect of overwhelming hospital ICU capacity was the primary driver of lockdowns, as governments sought to “flatten the curve” and manage infections. Certain countries were also forced to respond by building new capacity-dedicated facilities for severe COVID-19 patients, like the largely unused “Nightingale” hospitals in the UK.
The results also showed a reduction in risk of hospitalization for any cause with 14% relative risk reduction (24.8 in pre-specified 2EPs while the reductions in other 2EPs of hospitalization for HF or CV death or all-cause death were not statistically significant The safety data were consistent with the prior safety profile of Jardiance.
Image credit: marilyn barbone | stock.adobe.com Pharmacists as Key Players in Cardiovascular Treatment Plans Pharmacists are already crucial in managing medications for conditions like hypertension, hyperlipidemia, diabetes, and heart failure—all of which are significant risk factors for CVD.
Biocon Biologics shared the progress of the ongoing ‘Embedding Specialist Nurses in Diabetes Care’ project undertaken in collaboration with Diabetes Africa and St Paul’s Hospital Millennium Medical College in Ethiopia. Diabetes contributes to nearly 2 per cent of all deaths in the country*. Dr Sisay S.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content